This site is intended for healthcare professionals only
LoginRegister
Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trialPfizer Gets CDSCO Panel Nod to Conduct Phase IIIb Trial of Rimegepant for Menstrual Migraine
Sun Pharma unit Taro recalls over 17k units of antifungal medication in USSafety first: Aurobindo recalls discolored pain relieving drug in US
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresUSFDA lifts Risk Evaluation and Mitigation Strategies for CAR T cell therapies
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsUSFDA issues 1 observation for Granules Pharma USA facility
Breaking News: Health Ministry Bans Immediate-Release Nimesulide Oral Doses Above 100 mg14 Drugs Including Pomol-650, Glimiz-2 Banned in Karnataka, Check Full List
Akums Secures First UK MHRA Approval for RivaroxabanAkums Gets CDSCO Panel Nod for BE Study of Rizatriptan-Meloxicam FDC, Told to Revise Phase III...
CDSCO Asks Serum Institute to Revise Protocol for Trivalent Flu-COVID Vaccine TrialCDSCO Asks Serum Institute to Revise Protocol for Trivalent Flu-COVID Vaccine Trial
Accused ArrestedTwo arrested over counterfeit version of Sun Pharma drugs seized in Hyderabad
Sun Pharma ropes in Richard Ascroft as North America CEOSun Pharma ropes in Richard Ascroft as North America CEO
Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to StelaraBiocon Biologics Yesafili gets Health Canada nod for eye diseases
Safipur CHC Burns Medicines, Investigation LaunchedHealth Ministry Plans Licence Suspension for Drugs Failing Quality Standards: Report
Bharat Serums Gets CDSCO Panel Nod for Phase III Trial of IVIG in Chronic ITPBharat Serums Gets CDSCO Panel Nod for Phase III Trial of IVIG in Chronic ITP
X